Webinars

Jun 18, 2024

Flexible Capabilities to Enable Comprehensive Genomic Profiling

Presented at: The Power of Comprehensive Genomic Profiling Testing

1 +25pts

Speakers

Jeff Conroy

Chief Scientific Officer and Director Genomics Technologies OmniSeq Inc., Roswell Park Comprehensive Cancer Center
Jeremy Wallentine, MD

Pathologist Intermountain Health
Nikoletta Sidiropoulos, MD

Associate Professor & Director Molecular Pathology University of Vermont Larner College of Medicine
Moderator: Sue Beruti, MD, MHA

Sr. Medical Director, Clinical Genomics Illumina

Abstract

Comprehensive Genomic profiling (CGP) is becoming standard of care in oncology. It allows clinicians to maximize clinical information from limited biopsy samples so that patients are matched with approved therapies or enrolled in relevant clinical trials.

In this workshop, our panel will describe the implementation of a CGP assay at their institutions. They will also discuss how flexible automation, sample batching, data analysis and reporting solutions are key to offer CGP testing so that data access and turn-around time can benefit patients.

Learn:

Reasons to implement and value of a flexible future-proof DNA+RNA CGP assay.
The impact of reflex CGP testing on testing decision trees and workflow consolidation.
Value of sample management and genomic literacy for oncologists and molecular tumor boards.

Flexible Capabilities to Enable Comprehensive Genomic Profiling

Jeff Conroy

Jeremy Wallentine, MD

Nikoletta Sidiropoulos, MD

Moderator: Sue Beruti, MD, MHA